27 reports

It is mainly dedicated to the manufacturing and marketing of APIs and drug products of dermatology, anti-tuberculosis and oncology.

  • Leukemia
  • China
  • Nanjing Aosaikang Medicinal Group
  • Zhejiang Expressway Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

It is mainly dedicated to the manufacturing and marketing of APIs and drug products of dermatology, anti-tuberculosis and oncology.

  • Leukemia
  • China
  • Supply
  • Tianjin Tianyao Pharmaceutical Co., Ltd
  • Zhejiang Expressway Co., Ltd.
  • 5.2.4. T-CELL IMMUNOTHERAPIES: TARGET ONCOLOGICAL INDICATIONS

IN ADDITION TO THE AFOREMENTIONED THERAPIES, THE COMPANY HAS EIGHT DEVELOPMENT PROGRAMS IN PHASE I (TVI-LUNG-##, TVI-BREAST-##, TVI-COLON- ##, TVI-MELANOMA-##, TVI-OVARY-##, TVI-PROSTATE-##, TVI-LEUKEMIA-## AND TVI-PANCREAS-##) AND THRE

  • Leukemia
  • Company
  • Market Size
  • Juno Therapeutics Inc.
  • Novartis AG

THE FOCUS OF THIS EFFORT WILL BE IN HIV, TUBERCULOSIS (TB), AND MATERNAL, NEWBORN AND CHILD HEALTH.

  • Leukemia
  • AstraZeneca PLC
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

COLI INFECTIONS, HEPATITIS B, SARS, TUBERCULOSIS AND WHOOPING COUGH (BORDETELLA PERTUSSIS). ##. ##.

  • Leukemia
  • North America
  • United States
  • Ablynx NV
  • Amgen Inc.

Its products are used in the therapeutic areas of tuberculosis, malaria, influenza, and cancer.

  • Leukemia
  • Pharmaceutical
  • France
  • Deals & Alliance
  • Hybrigenics SA

There were no cases of tuberculosis or gastrointestinal perforations.

  • Leukemia
  • Therapy
  • United States
  • Product Initiative
  • Incyte Corporation
  • PIPELINE BY QURIENT CO LTD, H1 2018

It is developing products for the treatment of atopic dermatitis; extensively drug-resistant tuberculosis (XDR) and multi drug resistant (MDR) and totally drug resistant (TDR) tuberculosis (TB); asthma and cancer, among others.

  • Cancer
  • Leukemia
  • Therapy
  • United States
  • Product Initiative
  • Abbott Diagnostics Pipeline Products Overview

Lung Cancer PD-##/ PDL-## COMPANION DIAGNOSTIC ASSAY - LUNG CANCER PD-##/ PDL-## COMPANION DIAGNOSTIC ASSAY - LUNG CANCER PRODUCT OVERVIEW PD-##/ PDL-## COMPANION DIAGNOSTIC ASSAY - LUNG CANCER - PRODUCT STATUS PD-##/ PDL-

  • Cancer
  • Leukemia
  • Lung Cancer
  • Therapy
  • United States
  • PIPELINE BY IGNYTA INC, H2 2017
  • PIPELINE BY ONO PHARMACEUTICAL CO LTD, H2 2017

The company is developing products for the treatment of atopic dermatitis; extensively drug-resistant tuberculosis (XDR)/ multi drug resistant (MDR)/ totally drug resistant (TDR) tuberculosis (TB); asthma and cancer.

  • Cancer
  • Leukemia
  • Therapy
  • United States
  • Product Initiative

There were no cases of tuberculosis or gastrointestinal perforations.

  • Leukemia
  • Therapy
  • United States
  • Product Initiative
  • Incyte Corporation

The prominent features of this report are - ##.

  • Leukemia
  • Therapy
  • World
  • Product Initiative
  • Novartis AG

The prominent features of this report are - ##.

  • Blood Disease
  • Clinical Trial
  • Leukemia
  • Vaccine
  • Novartis AG

The prominent features of this report are - ##.

  • Drug Development
  • General Medicine And Specialty Medicine
  • Leukemia
  • World
  • Product Initiative

It provides preclinical and clinical proof to support further development of TriMix technology. eTheRNA also develops drugs for infectious diseases such as influenza, pneumonia, tuberculosis, Lyme disease, HIV and AIDS et cetera.

  • Antimalarials
  • Leukemia
  • Medical Biotechnology
  • World
  • Product Initiative

## ## ## ## ## ## ## ## ## ## ## ## GlaxoSmithKline Plc Galera Therapeutics Inc Novartis AG ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## MallInckrodt Plc Jazz Pharmaceuticals Plc Eisai Co Ltd CD Pharma India Pvt Ltd Biotec Pharmacon ASA Sourc

  • Clinical Trial
  • Leukemia
  • Lymphoma
  • World
  • Product Initiative

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Incyte Corp ## ## ## ## ## ## ## ## Bellicum Pharmaceuticals Inc ## ##

  • Leukemia
  • Monoclonal Antibody
  • Pharmaceutical
  • United States
  • World
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Blood Disease
  • Clinical Trial
  • Leukemia
  • Monoclonal Antibody
  • Novartis AG
  • PIPELINE BY QURIENT CO LTD, H1 2018

The company is developing products for the treatment of atopic dermatitis; extensively drug-resistant tuberculosis (XDR)/ multi drug resistant (MDR)/ totally drug resistant (TDR) tuberculosis (TB); asthama and cancer.

  • Leukemia
  • Oncology
  • Pharmaceutical
  • Therapy
  • Exelixis, Inc.

TUBERCULOSIS, M.

  • Cancer
  • Leukemia
  • Monoclonal Antibody
  • Therapy
  • Daiichi Sankyo Company
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Blood Disease
  • Cancer
  • Clinical Trial
  • Leukemia
  • Novartis AG

Food and Drug Administration (FDA) received in May 2016 regarding the QuantiFERON-TB test, the modern standard for detecting latent tuberculosis (TB) infection.

  • Clinical Trial
  • Leukemia
  • Therapy
  • United States
  • Pfizer Inc.
  • Pipeline by Cyclacel Pharmaceuticals Inc, H1 2018

The company is developing products for the treatment of atopic dermatitis; extensively drug-resistant tuberculosis (XDR)/ multi drug resistant (MDR)/ totally drug resistant (TDR) tuberculosis (TB); asthma and cancer.

  • Leukemia
  • Pharmaceutical
  • United States
  • Product Initiative
  • Syros Pharmaceuticals, Inc.
  • Novartis AG - Pipeline by Indication, 2016
  • Novartis AG - Dormant Developmental Projects,2016

One of the hits, indole-##-carboxamide analog (##), had low micromolar potency against Mycobacterium tuberculosis (Mtb), high mouse liver microsomal clearance, and low aqueous solubility.

  • Cancer
  • Leukemia
  • Targeted Therapy
  • Therapy
  • Novartis AG
  • Celgene Corporation - Dormant Developmental Projects,2016

The drug candidate is in Phase II stage of development for tuberculosis, erythema nodosum leprosum (ENL).

  • Cancer
  • Leukemia
  • Therapy
  • United States
  • Celgene Corporation
  • Bristol-Myers Squibb Company - Dormant Developmental Projects,2016

Chemokine (C-C Motif) Receptor ## (CCR##) Antagonist ## ## ## ## ## ## ## ## ## Chemokine (C-C Motif) Receptor ## (CCR##) Antagonist ## ## ## ## ## ## ## ## ## Cholesterylester Transfer Protein (CETP) Inhibitor ## ## ## ## ## ## ## ## ## Cyclin-Dependent Kinase ## (CDK

  • Leukemia
  • Research And Development
  • Therapy
  • United States
  • Bristol-Myers Squibb Company

Its products are used to treat HIV, tuberculosis and malaria.

  • Leukemia
  • Pharmaceutical
  • Renal Cancer
  • Therapy
  • BioLineRx Ltd.